Agilent Navigates Market Challenges: Q3 Exceeds Expectations As Strategic Investments Pay Off
Agilent Navigates Market Challenges: Q3 Exceeds Expectations As Strategic Investments Pay Off
The Diagnostics and Genomics Group (DGG) revenue stood at $385 million, down 9% Y/Y (-8% Y/Y core), with an operating margin of 18.3%.Agilent Technologies, Inc. (NYSE:A) shares are trading higher after the company reported third-quarter results yesterday.
Agilent Technologies, Inc. (纽交所:A)股票交易走高，该公司昨天发布了第三季度业绩报告。
Revenue fell 5.6% Y/Y to $1.58 billion, beating the consensus of $1.56 billion. By segment, the Life Sciences and Applied Markets Group (LSAG) segment reported revenue of $782 million, down 8% Y/Y (-7% Y/Y core), with an operating margin of 28.4%.
营业收入同比下降5.6%至15.8亿美元，超过了市场预期的15.6亿美元。按业务领域划分，生命科学与应用市场集团（LSAG）的营业收入为7.82亿美元，同比下降8%（核心同比下降7%），营业利润率为28.4%。
The Agilent CrossLab Group (ACG) revenue came in at $411 million, up 4% Y/Y (+5% Y/Y core), with an operating margin of 34.0%.
Agilent CrossLab集团（ACG）的营业收入为4.11亿美元，同比增长4%（核心同比增长5%），营业利润率为34.0%。
The Diagnostics and Genomics Group (DGG) revenue stood at $385 million, down 9% Y/Y (-8% Y/Y core), with an operating margin of 18.3%.
诊断与基因组学集团（DGG）的营业收入为3.85亿美元，同比下降9%（核心同比下降8%），营业利润率为18.3%。
As of July 31, cash and cash equivalents stood at $1.78 billion. Adjusted EPS of $1.32 surpassed the street view of $1.26.
截至7月31日，现金及现金等价物为17.8亿美元。调整后的每股收益为1.32美元，超过了市场预期的1.26美元。
Outlook: Agilent forecasts fourth-quarter revenue of $1.641 billion – $1.691 billion (vs. $1.67 billion estimate) and adjusted EPS of $1.38 – $1.42 (vs. street view of $1.44).
展望：Agilent预测第四季度的营业收入为16.41亿美元至16.91亿美元（市场预期为16.7亿美元），调整后的每股收益为1.38美元至1.42美元（市场预期为1.44美元）。
For FY24, Agilent revised its revenue outlook to $6.45 billion – $6.5 billion from $6.42 billion – $6.5 billion (vs. $6.46 billion estimate) and adjusted EPS to $5.21 – $5.25 (vs. $5.20 estimate) from $5.15 – $5.25 earlier.
对于2024财年，Agilent将其营业收入展望修正为6.45亿美元至6.5亿美元（市场预期为6.42亿美元至6.5亿美元），调整后的每股收益为5.21美元至5.25美元（市场预期为5.20美元），之前为5.15美元至5.25美元。
Agilent President and CEO Padraig McDonnell said, "While market conditions continued to be challenged during the quarter, we saw steady signs of improvement as anticipated. We continue to make investments in our most promising growth opportunities."
Agilent总裁兼首席执行官帕德里格·麦克唐纳表示：“尽管本季度市场环境依然具有挑战性，但我们看到了预期中的稳定好转迹象。我们将继续在最有前景的增长机会上进行投资。”
"And we are mobilizing the organization to accelerate value creation through strategic transformation initiatives, which will drive margin expansion and growth—and increase our execution capabilities."
我们正在调动组织力量，通过战略转型举措加速价值创造，这将推动利润扩张和增长，并提高我们的执行能力。
Investors can gain exposure to the stock via ProShares Nanotechnology ETF (NYSE:TINY) and VanEck ETF Trust VanEck Morningstar Wide Moat Growth ETF (BATS:MGRO).
投资者可以通过ProShares纳米科技ETF（NYSE：TINY）和VanEck ETF Trust VanEck晨星宽基成长ETF（BATS：MGRO）获得该股的曝光机会。
Price Action: A shares are up 1.88% at $142.63 at the last check Thursday.
价格波动：周四最新查看时，A股上涨1.88%，至142.63美元。
Image from Shutterstock
来自Shutterstock的图片
- EHang Q2 Revenue Skyrockets 920% with Record eVTOL Deliveries: Details
- 亿航Q2营业收入飙升920%，创纪录的eVTOL交付详细信息。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免责声明：本内容部分使用人工智能工具生成，并经Benzinga编辑审核发布。
